ATE360413T1 - Zusammensetzungen mit verzögerter freigabe, verfahren zu deren herstellung und verwendung - Google Patents

Zusammensetzungen mit verzögerter freigabe, verfahren zu deren herstellung und verwendung

Info

Publication number: ATE360413T1
Authority: AT; Austria
Prior art keywords: release compositions; salt; lactic acid; polymer; acid
Prior art date: 1999-07-15

Application number

AT00944418T

Other languages

English (en)

Inventor

Yasutaka Igari

Yoshio Hata

Kazumichi Yamamoto

Original Assignee

Takeda Pharmaceutical

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-07-15

Filing date

2000-07-13

Publication date

2007-05-15

2000-07-13 Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical

2007-05-15 Application granted granted Critical

2007-05-15 Publication of ATE360413T1 publication Critical patent/ATE360413T1/de

Links

239000000203 mixture Substances 0.000 title abstract 3
230000003111 delayed effect Effects 0.000 title 1
229920000642 polymer Polymers 0.000 abstract 3
150000003839 salts Chemical class 0.000 abstract 3
XBBVURRQGJPTHH-UHFFFAOYSA-N 2-hydroxyacetic acid;2-hydroxypropanoic acid Chemical compound OCC(O)=O.CC(O)C(O)=O XBBVURRQGJPTHH-UHFFFAOYSA-N 0.000 abstract 2
238000013268 sustained release Methods 0.000 abstract 2
239000012730 sustained-release form Substances 0.000 abstract 2
UPHOPMSGKZNELG-UHFFFAOYSA-N 2-hydroxynaphthalene-1-carboxylic acid Chemical compound C1=CC=C2C(C(=O)O)=C(O)C=CC2=C1 UPHOPMSGKZNELG-UHFFFAOYSA-N 0.000 abstract 1
239000013543 active substance Substances 0.000 abstract 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Biophysics (AREA)
Endocrinology (AREA)
Molecular Biology (AREA)
Reproductive Health (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Inorganic Chemistry (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Biological Depolymerization Polymers (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Polyesters Or Polycarbonates (AREA)

AT00944418T 1999-07-15 2000-07-13 Zusammensetzungen mit verzögerter freigabe, verfahren zu deren herstellung und verwendung ATE360413T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP20188799		1999-07-15

Publications (1)

Publication Number	Publication Date
ATE360413T1 true ATE360413T1 (de)	2007-05-15

Family

ID=16448493

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00944418T ATE360413T1 (de)	1999-07-15	2000-07-13	Zusammensetzungen mit verzögerter freigabe, verfahren zu deren herstellung und verwendung

Country Status (21)

Country	Link
US (2)	US7265157B1 (de)
EP (1)	EP1197208B1 (de)
KR (1)	KR20020012312A (de)
CN (1)	CN1361685A (de)
AT (1)	ATE360413T1 (de)
AU (1)	AU5853000A (de)
BR (1)	BR0012400A (de)
CA (1)	CA2378714A1 (de)
CZ (1)	CZ2002114A3 (de)
DE (1)	DE60034568T2 (de)
HK (1)	HK1042237A1 (de)
HU (1)	HUP0202880A3 (de)
IL (1)	IL147417A0 (de)
MX (1)	MXPA02000461A (de)
NO (1)	NO20020084L (de)
NZ (1)	NZ516466A (de)
PL (1)	PL352499A1 (de)
RU (1)	RU2002103718A (de)
SK (1)	SK342002A3 (de)
WO (1)	WO2001005380A1 (de)
ZA (1)	ZA200200347B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2316273A1 (en)	1998-01-16	1999-07-22	Takeda Chemical Industries, Ltd.	Sustained-release composition, method of its production and use thereof
CA2355186C (en) *	1998-12-15	2008-03-18	Takeda Pharmaceutical Company Limited	Process for producing polymer
DK1310517T4 (da)	2000-08-07	2011-01-17	Wako Pure Chem Ind Ltd	Mælkesyrepolymer og fremgangsmåde til fremstilling af denne
US20040116522A1 (en) *	2001-03-30	2004-06-17	Yutaka Yamagata	Medicinal solutions
EP1382350A4 (de) *	2001-04-25	2006-01-04	Takeda Pharmaceutical	Mittel zur prophylaxe vor postoperativem wiederauftreten von prämenopausalem brustkrebs
US6693134B2 (en) *	2001-05-29	2004-02-17	Chemokine Therapeutics Corporation	Bicyclic aromatic chemokine receptor ligands
TWI332407B (en) *	2001-06-29	2010-11-01	Takeda Chemical Industries Ltd	Controlled release composition and method of producting the same
US20050064039A1 (en) *	2001-12-26	2005-03-24	Tomomichi Futo	Novel microsphere and method for production thereof
DK1532985T3 (en)	2002-06-25	2016-12-05	Takeda Pharmaceuticals Co	PROCEDURE FOR PREPARING A COMPOSITION WITH LONG-TERM RELEASE
US8900636B2 (en) *	2003-07-23	2014-12-02	Evonik Corporation	Controlled release compositions
US7906125B2 (en)	2003-09-18	2011-03-15	Boston Scientific Scimed, Inc.	Solid or semi-solid therapeutic formulations
US20050064045A1 (en) *	2003-09-18	2005-03-24	Sheng-Ping Zhong	Injectable therapeutic formulations
TW200529890A (en)	2004-02-10	2005-09-16	Takeda Pharmaceutical	Sustained-release preparations
EP1679065A1 (de) *	2005-01-07	2006-07-12	OctoPlus Sciences B.V.	Zubereitung mit kontrollierter Freisetzung von Interferon auf PEGT/PBT-Block-Copolymer-Basis
US7862552B2 (en)	2005-05-09	2011-01-04	Boston Scientific Scimed, Inc.	Medical devices for treating urological and uterine conditions
US8263109B2 (en)	2005-05-09	2012-09-11	Boston Scientific Scimed, Inc.	Injectable bulking compositions
WO2007070563A2 (en) *	2005-12-13	2007-06-21	Harkness Pharmaceuticals, Inc.	Stable solid forms of enterostatin
EP1973558A4 (de) *	2005-12-13	2009-12-23	Harkness Pharmaceuticals Inc	Verfahren zur behandlung von adipositas mit enterostatin
CA2657578A1 (en) *	2006-07-11	2008-01-17	Harkness Pharmaceuticals, Inc.	Methods of treating obesity using satiety factors
US7858663B1 (en) *	2007-10-31	2010-12-28	Pisgah Laboratories, Inc.	Physical and chemical properties of thyroid hormone organic acid addition salts
TWI481424B (zh)	2006-12-18	2015-04-21	Takeda Pharmaceutical	緩釋性組成物及其製法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1996022786A1 (en) *	1995-01-23	1996-08-01	Takeda Chemical Industries, Ltd.	Sustained-release preparation and use
EP0839525B1 (de)	1996-10-31	2004-08-04	Takeda Chemical Industries, Ltd.	Zubereitung mit verzögerter Freisetzung
AU5678398A (en)	1997-01-29	1998-08-18	Takeda Chemical Industries Ltd.	Sustained-release microspheres, their production and use
CA2316273A1 (en) *	1998-01-16	1999-07-22	Takeda Chemical Industries, Ltd.	Sustained-release composition, method of its production and use thereof
JPH11269094A (ja) *	1998-01-16	1999-10-05	Takeda Chem Ind Ltd	徐放性組成物、その製造法および用途
CA2355186C (en) *	1998-12-15	2008-03-18	Takeda Pharmaceutical Company Limited	Process for producing polymer

2000
- 2000-07-13 CN CN00810405A patent/CN1361685A/zh active Pending
- 2000-07-13 NZ NZ516466A patent/NZ516466A/xx unknown
- 2000-07-13 HK HK02103567.5A patent/HK1042237A1/en unknown
- 2000-07-13 AT AT00944418T patent/ATE360413T1/de not_active IP Right Cessation
- 2000-07-13 BR BR0012400-1A patent/BR0012400A/pt not_active IP Right Cessation
- 2000-07-13 WO PCT/JP2000/004683 patent/WO2001005380A1/ja not_active Ceased
- 2000-07-13 HU HU0202880A patent/HUP0202880A3/hu unknown
- 2000-07-13 SK SK34-2002A patent/SK342002A3/sk not_active Application Discontinuation
- 2000-07-13 RU RU2002103718/14A patent/RU2002103718A/ru not_active Application Discontinuation
- 2000-07-13 CZ CZ2002114A patent/CZ2002114A3/cs unknown
- 2000-07-13 EP EP00944418A patent/EP1197208B1/de not_active Expired - Lifetime
- 2000-07-13 AU AU58530/00A patent/AU5853000A/en not_active Abandoned
- 2000-07-13 KR KR1020027000546A patent/KR20020012312A/ko not_active Withdrawn
- 2000-07-13 US US10/019,786 patent/US7265157B1/en not_active Expired - Fee Related
- 2000-07-13 PL PL00352499A patent/PL352499A1/xx not_active Application Discontinuation
- 2000-07-13 DE DE60034568T patent/DE60034568T2/de not_active Expired - Fee Related
- 2000-07-13 MX MXPA02000461A patent/MXPA02000461A/es not_active Application Discontinuation
- 2000-07-13 CA CA002378714A patent/CA2378714A1/en not_active Abandoned
- 2000-07-13 IL IL14741700A patent/IL147417A0/xx unknown
2002
- 2002-01-08 NO NO20020084A patent/NO20020084L/no not_active Application Discontinuation
- 2002-01-15 ZA ZA200200347A patent/ZA200200347B/en unknown
2007
- 2007-07-25 US US11/782,707 patent/US20080014237A1/en not_active Abandoned

Also Published As

Publication number	Publication date
MXPA02000461A (es)	2002-07-30
CZ2002114A3 (cs)	2002-04-17
EP1197208A4 (de)	2004-06-30
SK342002A3 (en)	2002-05-09
KR20020012312A (ko)	2002-02-15
HK1042237A1 (en)	2002-08-09
RU2002103718A (ru)	2003-10-10
US20080014237A1 (en)	2008-01-17
BR0012400A (pt)	2002-05-21
EP1197208A1 (de)	2002-04-17
DE60034568T2 (de)	2008-01-03
ZA200200347B (en)	2003-03-26
HUP0202880A3 (en)	2003-04-28
CN1361685A (zh)	2002-07-31
PL352499A1 (en)	2003-08-25
NO20020084D0 (no)	2002-01-08
IL147417A0 (en)	2002-08-14
EP1197208B1 (de)	2007-04-25
HUP0202880A2 (hu)	2003-01-28
DE60034568D1 (de)	2007-06-06
US7265157B1 (en)	2007-09-04
NZ516466A (en)	2003-02-28
CA2378714A1 (en)	2001-01-25
AU5853000A (en)	2001-02-05
WO2001005380A1 (fr)	2001-01-25
NO20020084L (no)	2002-03-14

Legal Events

Date	Code	Title	Description
2007-10-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE360413T1 (de)	2007-05-15	Zusammensetzungen mit verzögerter freigabe, verfahren zu deren herstellung und verwendung
ATE322513T1 (de)	2006-04-15	Milchsäurepolymer und verfahren zu dessen herstellung
MY142066A (en)	2010-08-30	Controlled release composition comprising lactic acid polymer, and method of producing the same
DE69926876D1 (de)	2005-09-29	Verbindungen, deren struktur derivate von glukuronsäure und glukosamin enthält, verfahren zu deren herstellung und deren verwendung
HUP0100221A2 (hu)	2001-06-28	Nyújtott hatású készítmény és eljárás az előállítására, valamint alkalmazása
DK0839525T3 (da)	2004-11-29	Præparat med forlænget frigivelse
MY139606A (en)	2009-10-30	Sustained-release composition and process for producing the same
NO914032D0 (no)	1991-10-14	Preparat med forlenget frigjoering og polymerer for fremstilling derav
GEP20053470B (en)	2005-02-25	N-Heteroaryl-Pyridinesulfonamide Derivatives and Their Use as Endothelin Antagonists
CA2523989A1 (en)	2005-06-16	Biodegradable branched polylactide derivatives capable of forming polymeric micelles, and their preparation method and use
DE69808086D1 (de)	2002-10-24	Ein verfahren zur herstellung von 1,4,7,10-tetraazacyclododecan-1,4,7-triessigsäure und deren derivaten
NO20004919D0 (no)	2000-09-29	FremgangsmÕte for fremstilling av 5-hydroksybenzo[b]tiofen-3- karboksylsyrederivater
ATE307809T1 (de)	2005-11-15	Neuartige pyrimidin-derivate und verfahren zu ihrer herstellung
JP2001510860A5 (de)	2006-01-05
TH101402B (th)	2010-05-26	สารผสมที่ออกฤทธิ์นาน และกรรมวิธีสำหรับผลิตสารเดียวกันนี้
ATE242760T1 (de)	2003-06-15	Tilidin-mesylat, verfahren zu dessen herstellung und pharmazeutische zusammensetzungen